Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Unlike natural GHRH, CJC-1295 has been modified to bind to albumin in the bloodstream, giving it a longer half-life and prolonged effects over several days
Its presence may reshape treatment algorithms, patient engagement, and the future of type 2 diabetes care
Key findings: People who received retatrutide at doses ranging from 1 mg to 12 mg experienced significant weight loss compared to the placebo group At 24 weeks, the percentage change in body weight ranged from -7.2% in the 1 mg group to -17.5% in the 12 mg group, compared to -1.6% in the placebo group At 48 weeks, the percentage change in body weight ranged from -8.7% in the 1 mg group to -24.2% in the 12 mg group, compared to -2.1% in the placebo group A large proportion of people receiving retatrutide (64% to 100%) achieved a weight reduction of 5% or more, with some participants even losing 30% or more of their baseline weight Retatrutide treatment showed improvements in cardiometabolic measures, including reductions in glycated haemoglobin (HbA1c), fasting glucose, insulin, blood pressure, and lipid levels Safety and tolerability The safety profile was generally favourable, with the most common side effects of retatrutide being mild to moderate gastrointestinal issues, such as nausea, vomiting, diarrhoea, and constipation
While the evidence base remains early-stage, the peptides reclassification gives dermatology prescribers an additional compounding option for patients with inflammatory skin conditions that have been inadequately controlled by conventional therapies
Semaglutide GLP-1 is an effective weight loss treatment that helps regulate appetite by mimicking a hormone in the body
(Note: Losing Weight RX also offers tirzepatide.) Insurance reimbursement: In some cases, brand-name medications prescribed through Ro may qualify for partial insurance reimbursement, which could offset the higher cost
